Quoin Pharmaceuticals (QNRX) Total Debt (2020 - 2023)

Quoin Pharmaceuticals has disclosed Total Debt across 4 years of filings, most recently posting $4.0 million for Q1 2023.

• In Q1 2023, Total Debt changed N/A year-over-year to $4.0 million; the TTM figure through Mar 2023 stood at $4.0 million (changed N/A YoY), while the FY2022 annual figure was $7.6 million, up 61.89% from the prior year.
• Total Debt came in at $4.0 million for Q1 2023 at Quoin Pharmaceuticals, down from $7.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $7.6 million in Q4 2022 to a low of $4.0 million in Q1 2023.
• Average Total Debt over 4 years is $5.2 million, with a median of $4.6 million recorded in 2021.
• Year-over-year, Total Debt retreated 22.59% in 2021 and surged 61.89% in 2022.
• Over 4 years, Total Debt stood at $6.1 million in 2020, then dropped by 22.59% to $4.7 million in 2021, then surged by 61.89% to $7.6 million in 2022, then plunged by 47.38% to $4.0 million in 2023.
• Per Business Quant data, the three most recent Total Debt figures were $4.0 million in Q1 2023, $7.6 million in Q4 2022, and $4.3 million in Q3 2022.